Home/Filings/4/0000950170-25-102465
4//SEC Filing

Tattoli Mark Damian 4

Accession 0000950170-25-102465

CIK 0001958086other

Filed

Aug 4, 8:00 PM ET

Accepted

Aug 5, 9:21 AM ET

Size

9.7 KB

Accession

0000950170-25-102465

Insider Transaction Report

Form 4
Period: 2025-08-01
Tattoli Mark Damian
SVP, Gen Counsel & Secretary
Transactions
  • Exercise/Conversion

    Common Stock

    2025-08-01+25016,393.621 total
  • Tax Payment

    Common Stock

    2025-08-01$10.53/sh99$1,04216,294.621 total
  • Exercise/Conversion

    Restricted Shares

    2025-08-012502,150 total
    Common Stock (250 underlying)
Holdings
  • Common Stock

    (indirect: 401 (k) Plan)
    1,694.842
  • Common Stock

    (indirect: Custodial account)
    20
Footnotes (2)
  • [F1]The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date.
  • [F2]Multiple restricted share grants are included in this total.

Documents

1 file

Issuer

Core Laboratories Inc. /DE/

CIK 0001958086

Entity typeother

Related Parties

1
  • filerCIK 0001872069

Filing Metadata

Form type
4
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 9:21 AM ET
Size
9.7 KB